November 18th 2024
Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.
Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies
November 13, 2024 | 1:00 PM & 8:00 PM ET
View More
Closing Gaps in CLL Care: Managed Care Insights and Strategies
November 19, 2024 | 1:00 PM ET
View More
Emerging Trends in the Use of FGFR Inhibitors for Advanced Cholangiocarcinoma Treatment
1.0 Credits / Oncology
View More
Balancing the Benefits and Risks of Asparaginase Treatment in Adults and Young Adults With Acute Lymphoblastic...
1.0 Credits / Oncology
View More
Balancing Anticancer Efficacy and Cardiovascular Safety: A Pharmacist's Guide
1.0 Credits / Oncology
View More
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
1.0 Credits / Oncology
View More
Maximizing Efficacy and Minimizing Toxicity of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer
1.0 Credits / Oncology
View More
Optimizing Use of Small Molecule Inhibitors in Chronic Lymphocytic Leukemia: Strategies for Safe and Effective...
1.0 Credits / Hematology, Oncology
View More
Recognizing the Signs and Symptoms of Cytokine Release Syndrome in Novel Cancer Therapies: Strategies for Onco...
1.0 Credits / Oncology
View More
Revolutionizing the Treatment of Endometrial Cancer by Leveraging the Potential of Immune Checkpoint Inhibitor...
1.0 Credits / Oncology
View More
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
2.0 Credits / Nephrology, Oncology
View More
Advancements in Extensive-Stage Small Cell Lung Cancer Therapy: Integrating Clinical Evidence to Fill Gaps in ...
December 4, 2024 | 1:00 PM & 8:00 PM ET
View More
Advances in the Treatment of Metastatic Renal Cell Carcinoma: New Horizons in Targeted Therapies
1.0 Credit / Genitourinary Cancer, Oncology
View More
Optimizing Asparaginase Use in Acute Lymphoblastic Leukemia: A Comprehensive Program on Safety and Efficacy
1.0 Credit / Genitourinary Cancer, Oncology
View More
Navigating Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatment: An Interdisciplinary Approach
1.5 Credits / Oncology
View More
Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations
December 17, 2024 | 1:00 PM & 8:00 PM ET
View More
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and...
December 18, 2024 | 1:00 PM & 8:00 PM ET
View More
Mastering Oncology Clinical Trials: Immune Checkpoint Inhibitors in Frontline Metastatic Non–Small Cell Lung C...
1.5 Credits / Lung Cancer, Oncology
View More
Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma
December 19, 2024 | 7:00 PM ET
View More
Navigating the Evolving Landscape of HER2-Positive Early-Stage Breast Cancer: Considerations for Managed Care
2.0 Credits / Breast Cancer, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
1.0 Credits / Hematologic Cancer, Oncology
View More
Revolutionizing Multiple Myeloma Care: CAR T-Cell Therapy, Bispecific Antibodies, and Patient-Centered Strateg...
1.0 Credit / Oncology, Hematologic Cancer
View More
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Renal Cell Carcinoma
2.0 Credits / Oncology
View More
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
0.5 Credit / Oncology
View More
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a...
2.0 Credits / Oncology
View More
Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based C...
1.0 Credit / Hematologic Cancer, Oncology
View More
Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise
1.0 Credit / Hematologic Cancer, Oncology
View More
Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists
1.0 Credit / Hematologic Cancer, Oncology
View More
Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operati...
1.0 Credit / Hematologic Cancer, Oncology
View More
Personalized Survivorship Plans for Colon Cancer Patients Receiving Adjuvant Chemotherapy
October 23rd 2023Survivorship care for patients with colon cancer should include comprehensive coordination between oncologists, specialists, and primary care providers and include psychological and economic factors in addition to standard health recommendations.
Race, Ethnicity Data in Screening Model Could Reduce Lung Cancer Screening Disparities
September 21st 2023The ‘life-years gained from screening–computed tomography’ lung cancer screening model is recommended by the American College of Chest Physicians for personalizing patients’ shared decision-making in screening for lung cancer.
High BMI in Breast Cancer Patients Linked With Increased Cardiotoxicity During Chemotherapy
August 9th 2023A recent study being presented at the American College of Cardiology Latin America 2023 conference found the prevalence of cardiotoxicity among patients with breast cancer undergoing chemotherapy was 11.94%.